Cocrystal Pharma, Inc. — Cash Flow Charts
31 quarters of history · ending 2020-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-208.4% -$4M
$-2M
Free Cash Flow↑+0.0% +$0
$-1K
Investing Cash Flow↓-272.0% -$68K
$-93K
Financing Cash Flow↑+36.0% +$956K
$4M
Capex↑+0.0% +$0
$1K
Acquisitions
$0
Stock-Based Comp↑+103.1% +$101K
$199K
Debt Issued
$0
Debt Repaid
$22K
D&A↑+55.2% +$16K
$45K
SBC Allocated Expense↑+63.3% +$62K
$160K
SBC Unrecognized Cost↑+365.9% +$8M
$11M